Fresenius Kabi Recalls Hydralazine Due to Incorrect Expiration Date
Fresenius Kabi USA recalls 93,000 vials of Hydralazine Hydrochloride Injection due to an incorrect expiration date printed on the secondary packaging.
Use caution until it’s fixed
Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)
Contact the company
What happened, in plain English
Fresenius Kabi USA, LLC is recalling a specific lot of Hydralazine Hydrochloride Injection because the expiration date printed on the tray does not match the actual expiration. The product in question contains 20 mg/mL of the drug in a 1 mL fill within a 2 mL single-dose vial. This discrepancy affects the ability to verify how long the medication remains effective and safe for use. Read more at govinfonow.com/recall/43881-fresenius-kabi-usa-llc-recalls-hydralazine-hydrochloride-injection-usp-20.
Source Summary by GovInfoNow · govinfonow.com/recall/43881-fresenius-kabi-usa-llc-recalls-hydralazine-hydrochloride-injection-usp-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1327-2015
Cite this page
“Fresenius Kabi Recalls Hydralazine Due to Incorrect Expiration Date.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43881-fresenius-kabi-usa-llc-recalls-hydralazine-hydrochloride-injection-usp-20. Based on FDA recall #D-1327-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1327-2015%22&limit=1).
Why it’s dangerous
The hazard stems from a labeling error where the secondary packaging displays an incorrect expiration date ('11/06' instead of '11/2016'). This creates confusion regarding the product's shelf life, potentially leading to the use of medication that may have degraded or lost potency.
Who’s affected
Healthcare providers, pharmacies, and patients who have received or possess Hydralazine Hydrochloride Injection with NDC 63323-614-01 and Lot #6110593. These individuals are at risk of using medication past its verified expiration date if the error is not identified.
How to tell if you have this one
Check for Hydralazine Hydrochloride Injection, USP, 20 mg/mL, in a 2 mL single-dose vial. Look specifically for NDC 63323-614-01 and Lot #6110593. Verify if the expiration date printed on the tray is '11/06', which is the incorrect date associated with this recall.
- Brand
Fresenius Kabi- Category
Drug
What to do — step by step
Identify Affected Product
Check your inventory for Hydralazine Hydrochloride Injection, USP, 20 mg/mL, NDC 63323-614-01, Lot #6110593.
Verify Expiration Date
Confirm if the expiration date printed on the tray is '11/06', which indicates the product is part of this recall.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Fresenius Kabi recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1327-2015 (July 28, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1327-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.